---
title: "EW: Q2 sales up 12.5% year-over-year; guidance raised on strong TAVR and TMTT growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293676466.md"
description: "Q2 sales grew 12.5% year-over-year, driven by strong TAVR, TMTT, and surgical performance. Full-year sales guidance was raised to 10%-11%, with robust operating margins and EPS outlook. Key catalysts include new product launches, regulatory milestones, and expanded indications.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T23:12:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293676466.md)
  - [en](https://longbridge.com/en/news/293676466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293676466.md)
generator: "portal-rs"
---

# EW: Q2 sales up 12.5% year-over-year; guidance raised on strong TAVR and TMTT growth

Q2 sales grew 12.5% year-over-year, driven by strong TAVR, TMTT, and surgical performance. Full-year sales guidance was raised to 10%-11%, with robust operating margins and EPS outlook. Key catalysts include new product launches, regulatory milestones, and expanded indications.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [EW.US](https://longbridge.com/en/quote/EW.US.md)

## Related News & Research

- [Edwards Lifesciences CVP EMEACLA Annette Bruls sells 2,644 shares worth $237,903.12](https://longbridge.com/en/news/297366466.md)
- [Edwards Lifesciences' Donald E. Bobo, Jr. to Retire as Corporate VP; Successor Search Underway](https://longbridge.com/en/news/297366021.md)
- [Heartflow FFRCT trial data show 44% drop in unnecessary invasive heart catheterizations](https://longbridge.com/en/news/297276738.md)
- [Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says](https://longbridge.com/en/news/293778081.md)
- [Humacyte says Phase 3 V012 trial shows ATEV extends catheter-free dialysis time in women](https://longbridge.com/en/news/296784335.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**